CAS RN: 6734-33-4
4-METHYLUMBELLIFERYL-BETA-D-XYLOPYRANOSIDE
Product Availability
Choose a grade to view its available package options.
8 package records7 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20250421 |
100mg |
In stock |
Shanghai | Inquiry |
| Batchno.20260223 |
1g |
In stock |
Shenzhen, Wuhan | Inquiry |
| Batchno.20251010 |
1g |
In stock |
Shanghai, Chongqing | Inquiry |
| Batchno.20250610 |
250mg |
In stock |
Shanghai, Wuhan | Inquiry |
| Batchno.20251201 |
250mg |
In stock |
Shanghai, Shandong, Chongqing, Hebei | Inquiry |
| Batchno.20250509 |
50mg |
In stock |
Shanghai, Shandong, Hebei | Inquiry |
| Batchno.20260618 |
5g |
Out of stock |
| Inquiry |
| Batchno.20250210 |
5g |
In stock |
Shanghai, Shandong | Inquiry |
-
Product code:
starshine_CAS6734-33-4
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
6734-33-4 / 4-methyl-7-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxychromen-2-one
Standard CAS: 6734-33-4
Multi CAS: Yes
Basic Information
CAS
6734-33-4
Multi CAS
Yes
Molecular Formula
C15H16O7
Molecular Weight
308.280000
Exact Mass
308.089603
InChI
InChI=1S/C15H16O7/c1-7-4-12(17)22-11-5-8(2-3-9(7)11)21-15-14(19)13(18)10(16)6-20-15/h2-5,10,13-16,18-19H,6H2,1H3/t10-,13+,14-,15+/m1/s1
InChIKey
JWIYLOHVJDJZOQ-KAOXEZKKSA-N
Computed Properties
Structural Parameters
Heavy atom count
22
Aromatic heavy atom count
10
Fraction Csp3
0.4
Rotatable bonds
2
H-bond acceptors
7
H-bond donors
3
Molar refractivity
75.61
TPSA
109.36
LogP / Solubility
WLOGP
-0.08
MLOGP
-0.06
XLogP3
-0.7
Consensus LogP
-0.28
Log S (ESOL)
-1.9
Class (ESOL)
Soluble
Log S (Ali)
-2.03
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-1.84
Class (SILICOS-IT)
Soluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-4.66
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
Yes
Synthetic Accessibility
4.5